Ardent Health, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
In November 2025, our Board of Directors authorized a stock repurchase program pursuant to which we may repurchase an
aggregate of up to $50.0 million of our common stock through open market purchases, privately negotiated transactions,
block trades or other transactions in accordance with applicable securities laws, subject to market conditions and other
factors. The program has no expiration date. At March 31, 2026, there was approximately $46.8 million of stock repurchase
authorization remaining under the stock repurchase program. We did not repurchase any shares under the stock repurchase
program during the three months ended March 31, 2026.
During the three months ended March 31, 2026, we made the following purchases of our equity securities that are registered
pursuant to Section 12(b) of the Securities Exchange Act of 1934 (dollars in millions, except per share amounts):
| Period · Total Number of Shares Purchased(1) · Average Price Paid per Share · Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs · Maximum Dollar Value That May Yet Be Purchased Under Publicly Announced Plans or Programs | |||||
|---|---|---|---|---|---|
| January 1, 2026 - January 31, 2026 | 13,767 | $8.73 | — | $46.8 | |
| February 1, 2026 - February 28, 2026 | 4,676 | 8.96 | — | $46.8 | |
| March 1, 2026 - March 31, 2026 | 101,078 | 8.71 | — | $46.8 | |
| Total | 119,521 | $8.72 | — | ||
| (1) | Includes 119,521 shares withheld by us to satisfy the payment of tax obligations related to the vesting of restricted stock unit awards. | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.